Aug. 12 at 8:23 PM
$QTI is pleased to report strong results for the second quarter of 2026.
- Over 12,000 women have already been imaged using our technology, an important milestone as we continue building a quantitative breast imaging platform designed to advance breast health management
-
$7.4 million in Q2 revenue, up 103% year-over-year
- 15 Breast Acoustic CT™ scanners shipped during the quarter
- 28 scanners shipped in the first half of 2026
- Expanded our direct U.S. commercial organization
- Received regulatory authorization in Israel and Saudi Arabia
- Successfully completed our first routine FDA inspection with zero Form 483 observations
- Expanded manufacturing capacity with our new 22,000-square-foot facility in Petaluma, California
These milestones reflect the continued execution of our team as we strengthen the clinical, commercial, regulatory, and operational foundation needed to bring Breast Acoustic CT™ to more clinicians and patients around the world.
Read more: https://ir.qtimaging.com/news-events/press-releases/detail/161/qt-imaging-delivers-strong-second-quarter-growth-while-building-the-foundation-for-commercial-scale